Document Detail


Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea.
MedLine Citation:
PMID:  8276957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Between 1979 and 1990, 73 patients suffering from hypothalamic amenorrhoea were treated by pulsatile administration of gonadotrophin releasing hormone (GnRH) in 359 treatment cycles. Seventy-two pregnancies were achieved. In 64 favourable patients in whom hypothalamic amenorrhoea constituted the only reason for infertility, a pregnancy rate of 29% per cycle could be obtained. Patients who conceived during pulsatile GnRH required an average of only 2.4 cycles per conception. Twelve out of 24 patients with hypothalamic amenorrhoea who exhibited an ovulatory response to pulsatile GnRH, ovulated during oral administration of naltrexone; such responsiveness to opioid antagonism was, however, restricted to the less serious grades. In conclusion, pulsatile administration of GnRH continues to be a highly effective mode of treatment of infertility due to hypothalamic amenorrhoea of various aetiologies. A subgroup of these patients may be successfully treated by the oral administration of naltrexone.
Authors:
G Leyendecker; S Waibel-Treber; L Wildt
Related Documents :
3091407 - Cross-over trial of superovulation protocols from two major in vitro fertilization cent...
16595197 - A new era in ovulation induction.
10920087 - Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant...
12005307 - Results of intracytoplasmic sperm injection of single oocyte in 362 unstimulated cycles.
2680627 - The potential diagnostic use of human zona-free eggs prepared from oocytes that failed ...
22916557 - Reproductive health characteristics of young malawian women seeking post-abortion care.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  8 Suppl 2     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1994-02-10     Completed Date:  1994-02-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  184-8     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Academic Teaching Hospital, University of Frankfurt, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amenorrhea / drug therapy*,  etiology,  physiopathology
Female
Gonadotropin-Releasing Hormone / administration & dosage*,  therapeutic use
Humans
Hypothalamic Diseases / complications*
Infertility, Female / drug therapy,  etiology
Naltrexone / administration & dosage*,  therapeutic use
Ovulation
Periodicity
Pregnancy
Chemical
Reg. No./Substance:
16590-41-3/Naltrexone; 33515-09-2/Gonadotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulsatile GnRH treatment in boys and girls with idiopathic hypogonadotrophic hypogonadism.
Next Document:  Multiple follicular growth under pulsatile gonadotrophin releasing hormone stimulation.